본문으로 건너뛰기
cccskills
무료GitHub에 공개

endo-cgm-confirmatory-pocbg-high-risk-hypoglycemia

Recommends real-time CGM with confirmatory bedside POC-BG monitoring for insulin dosing adjustments rather than POC-BG testing alone in adults with insulin-treated diabetes at high risk of hypoglycemia. Consider this approach for patients aged ≥65 years, BMI ≤27 kg/m², total daily insulin dose ≥0.6 units/kg, CKD stage ≥3, or recent hypoglycemia.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL

실행 점수 미검증

설치 방법 보기

포함된 파일(1)

  • SKILL.md2.6 KB

SKILL.md(원문)

설치하기 전에 에이전트에게 전달되는 지시 내용을 확인할 수 있습니다.

Use CGM with confirmatory POC-BG monitoring for insulin adjustments in high-risk hypoglycemia patients

STEP 1 — Gather Information

Collect age, BMI, total daily insulin dose (units/kg), CKD stage (eGFR), recent hypoglycemia history, and confirm insulin-treated diabetes with noncritical illness hospitalization.

STEP 2 — Rule In / Rule Out

If any of the following are present: age ≥65 years, BMI ≤27 kg/m², total daily insulin dose ≥0.6 units/kg, CKD stage ≥3 (eGFR <60 mL/min/1.73m²), or documented recent hypoglycemia → classify as high risk; otherwise, classify as not high risk.

STEP 3 — Classify or Stratify

If high risk, evaluate hospital availability of CGM devices, training, and protocols; if resources/training are available → select CGM with confirmatory POC-BG monitoring; if not available → select POC-BG testing alone.

STEP 4 — Decide

Implement the selected monitoring strategy to guide insulin dosing adjustments; document glucose trends and adjust insulin accordingly.

Clinical Guardrails / Mimics / Pitfalls

Do not rely solely on CGM without confirmatory POC-BG for insulin dosing; avoid CGM in patients with extensive skin infections, hypoperfusion, hypovolemia, or receiving vasoactive/pressor therapy; beware of medications causing CGM interference (acetaminophen >4 g/day, dopamine, vitamin C, hydroxyurea); ensure CGM resources and training are available before deployment.

Concrete Clinical Example

A 70-year-old woman with type 2 diabetes on basal-bolus insulin admitted for pneumonia (noncritical illness) has age 70, BMI 24, TDD 0.8 units/kg, CKD stage 3b; hospital has CGM resources. Real-time CGM with confirmatory POC-BG is initiated; a trend down triggers a confirmatory POC-BG of 68 mg/dL, leading to basal insulin hold and carbohydrate intake, preventing severe hypoglycemia.

Source: Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2022, https://doi.org/10.1210/clinem/dgac278

TODO: consider adding scripts/calc.py for the endo-cgm-confirmatory-pocbg-high-risk-hypoglycemia calculator

리뷰

아직 리뷰가 없습니다. 사용해 본 소감을 남겨 주세요.

댓글

로그인 없이 쓸 수 있습니다. 사용 후기, 질문, 작동하지 않은 환경 등을 편하게 남겨 주세요.

아직 댓글이 없습니다. 첫 댓글을 남겨 보세요.

보내면 바로 공개됩니다. 이메일 주소나 전화번호 같은 개인 정보는 쓰지 마세요. URL은 2개까지입니다.

0 / 1,000자

이 양식은 reCAPTCHA로 보호되며 Google 개인정보처리방침 및 서비스 약관이 적용됩니다.

같은 저장소의 스킬

780g-pump-adjustment

무료

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

ata-acth-stim-test-interpretation

무료

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

ata-adrenal-crisis-treatment

무료

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

ata-aed-ai-education

무료

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

ata-aed-lt4-monitoring

무료

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

ata-cortisol-cutoff-ai-diagnosis

무료

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

dromlakhani/MD2SKILL142026년 10월 20일 업데이트

dromlakhani의 스킬 모두 보기

이 스킬의 문제 신고